Dianthus Therapeutics, Inc.
DNTH NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 4, 2026
ET
EPS Est.
-0.85
EPS Actual
-0.90
Revenue Est.
$297182
Revenue Actual
$761000
Next Earnings Report Date unconfirmed
Date
Nov 5, 2026 · Thu
ET Nov 5, 2026 · Thu
Time
11/5 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.94
Revenue Est.
$443851
Company Overview
Dianthus Therapeutics, Inc. (ticker DNTH) is listed on NASDAQ with a market cap of about $5.42B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.94. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Nov 3, 2022 → Aug 4, 2026
Nov 3, 2022Range: -7.52 ~ -0.51Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -0.85 | Below forecast↓-0.90 | $297182 | $761000 |
| May 5, 2026 | -- | -1.17 | Above forecast↑-0.85 | $403615 | $463000 |
| Mar 9, 2026 | -- | -0.98 | Below forecast↓-1.43 | $552231 | $284000 |
| Nov 5, 2025 | -- | -0.86 | Below forecast↓-0.97 | $576000 | $396000 |
| Aug 7, 2025 | -- | -0.86 | Below forecast↓-0.88 | $858200 | $193000 |
| May 12, 2025 | -- | -0.86 | Above forecast↑-0.82 | $806900 | $1.2M |
| Mar 11, 2025 | -- | -0.85 | Above forecast↑-0.81 | $955222 | $1.3M |
| Nov 7, 2024 | -- | -0.59 | Below forecast↓-0.74 | $741143 | $2.2M |
| Aug 8, 2024 | -- | -0.55 | Above forecast↑-0.51 | $368857 | $1.9M |
| May 9, 2024 | -- | -0.43 | Below forecast↓-0.54 | $464250 | $874000 |
| Mar 21, 2024 | -- | -1.11 | Above forecast↑-0.71 | $548500 | $457000 |
| Nov 9, 2023 | -- | -0.51 | Below forecast↓-3.78 | $250000 | $924000 |
| Aug 3, 2023 | -- | -0.80 | Below forecast↓-3.12 | -- | $1M |
| May 15, 2023 | -- | -6.40 | Below forecast↓-7.52 | -- | $476000 |
| Nov 3, 2022 | -- | -4.64 | Above forecast↑-4.32 | -- | $1.2M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-04 ↗
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-03-09 ↗
Earnings Release8-K · 2026-03-09 ↗
Quarterly10-Q · 2025-11-05 ↗
Earnings Release8-K · 2025-11-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
